Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 847373, 10 pages
http://dx.doi.org/10.1155/2015/847373
Research Article

Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis

1Institute of Clinical Medicine, College of Medicine, National Cheng-Kung University, No. 35, Siao-Dong Road, Tainan 70403, Taiwan
2Department of Ophthalmology, National Cheng-Kung University Hospital, Tainan 70403, Taiwan
3Department of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 10051, Taiwan
4Department of Microbiology and Immunology, College of Medicine, National Cheng-Kung University, Tainan 70101, Taiwan
5Department of Pediatrics, National Cheng-Kung University Hospital, Tainan 70403, Taiwan

Received 16 May 2014; Revised 5 September 2014; Accepted 7 September 2014

Academic Editor: Andrzej Grzybowski

Copyright © 2015 Sheng-Min Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sheng-Min Hsu, Chang-Hao Yang, Fang-Hsiu Shen, Shun-Hua Chen, Chia-Jhen Lin, and Chi-Chang Shieh, “Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis,” Mediators of Inflammation, vol. 2015, Article ID 847373, 10 pages, 2015. https://doi.org/10.1155/2015/847373.